We are live on ! Find out more
AP

Antipodes Partners Portfolio holdings

AUM $5.46B
1-Year Est. Return 26.64%
This Fund
S&P 500
This Quarter Est. Return
+4.52%
1 Year Est. Return
+26.64%
3 Year Est. Return
+96.4%
5 Year Est. Return
+160.76%
10 Year Est. Return
AUM
$5.19B
AUM Growth
+$431M
Cap. Flow
+$353M
Cap. Flow %
6.8%
Top 10 Hldgs %
35.34%
Holding
153
New
23
Increased
48
Reduced
47
Closed
27

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$130M
2
HTO
H2O America
HTO
+$102M
3
DIS icon
Walt Disney
DIS
+$69.5M
4
WDAY icon
Workday
WDAY
+$69M
5
PGR icon
Progressive
PGR
+$60.7M

Sector Composition

Rank Sector Weight
1 Utilities 28.74%
2 Technology 13.47%
3 Healthcare 12.72%
4 Energy 9.26%
5 Consumer Discretionary 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANL
126
Adlai Nortye
ANL
$891M
$14.2K ﹤0.01%
+2,051
New +$13.7K
ALLY icon
127
CALL
Ally Financial
ALLY
$13.4B
-8,935
Closed -$760K
AMD icon
128
Advanced Micro Devices
AMD
$799B
-293,078
Closed -$62.8M
APGE icon
129
Apogee Therapeutics
APGE
$10.2B
-723
Closed -$54.6K
ARRY icon
130
Array Technologies
ARRY
$809M
-1,715
Closed -$15.8K
ASHR icon
131
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
-56,694
Closed -$1.86M
CENX icon
132
Century Aluminum
CENX
$4.55B
-423,789
Closed -$16.6M
DAWN
133
DELISTED
Day One Biopharmaceuticals
DAWN
-2,559
Closed -$23.9K
ESTA icon
134
Establishment Labs
ESTA
$2.33B
-969
Closed -$70.6K
FOLD
135
DELISTED
Amicus Therapeutics
FOLD
-3,926
Closed -$55.9K
GPCR icon
136
PUT
Structure Therapeutics
GPCR
$3.74B
-48
Closed -$30K
GTLB icon
137
GitLab
GTLB
$6.03B
-27,433
Closed -$1.03M
HON icon
138
CALL
Honeywell
HON
$76.3B
-2,067
Closed -$604K
JANX icon
139
Janux Therapeutics
JANX
$982M
-720
Closed -$9.94K
KO icon
140
Coca-Cola
KO
$374B
-145,423
Closed -$10.2M
LEN icon
141
Lennar Class A
LEN
$20.4B
-335,039
Closed -$34.4M
LSPD icon
142
Lightspeed Commerce
LSPD
$1.32B
-1,024,963
Closed -$12.4M
MDT icon
143
Medtronic
MDT
$110B
-730
Closed -$70.1K
MGNI icon
144
Magnite
MGNI
$3.49B
-24,831
Closed -$403K
MNDY icon
145
monday.com
MNDY
$3.7B
-2,381
Closed -$351K
NE icon
146
Noble Corp
NE
$6.5B
-257,244
Closed -$7.27M
NOVT icon
147
Novanta
NOVT
$5.82B
-449
Closed -$53.4K
SG icon
148
Sweetgreen
SG
$698M
-51,873
Closed -$351K
SGMT icon
149
Sagimet Biosciences
SGMT
$540M
-3,176
Closed -$18.8K
SHLS icon
150
Shoals Technologies Group
SHLS
$1.45B
-978
Closed -$8.31K

Similar funds

Antipodes Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Antipodes Partners held 153 positions worth $5.19B, up 9.1% from $4.76B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Antipodes Partners deployed $353M of net new capital in Q1 2026, opening 23 new positions and adding to 48 existing holdings. Its largest new stake was NVIDIA: 710,665 shares worth $124M.

By sector, the portfolio is most concentrated in Utilities at 29% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $53.2M trimmed.

  • Antipodes Partners's largest Q1 2026 buy was NVIDIA: 710,665 shares worth $124M.
  • Antipodes Partners added most to H2O America in Q1 2026, an estimated $102M increase.
  • Antipodes Partners's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $53.2M.
  • Antipodes Partners fully exited Advanced Micro Devices in Q1 2026, selling an estimated $62.8M.
  • Antipodes Partners's ten largest holdings make up 35% of its $5.19B portfolio in Q1 2026.
  • Antipodes Partners opened 23 new positions and closed 27 in Q1 2026.
  • Antipodes Partners's portfolio value rose 9.1% quarter-over-quarter to $5.19B.

Based on Antipodes Partners's 13F filing for Q1 2026, filed 5 May 2026.